| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/08/2011 | CN101628115B Liquid medicine for treating empyrosis |
| 06/08/2011 | CN101472612B Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof |
| 06/07/2011 | US7956043 oligonucleotides having a '5TCG motif without any additional unmethylated CpG motifs have strong immunostimulatory capability |
| 06/07/2011 | US7956041 Prophylactic and therapeutic agent of diabetes mellitus |
| 06/07/2011 | US7956040 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 06/07/2011 | US7956030 Method for reducing pain with ziconotide and baclofen |
| 06/07/2011 | US7955834 Method for improved breast milk feeding to reduce the risk of allergy |
| 06/07/2011 | US7955790 Skin substitutes with improved barrier function |
| 06/07/2011 | US7955614 Microfabricated nanopore device for sustained release of therapeutic agent |
| 06/07/2011 | US7955598 Therapeutic agent for chronic arthritides diseases of childhood-related diseases |
| 06/07/2011 | CA2555824C Fused-ring 4-oxopyrimidine derivative |
| 06/07/2011 | CA2490573C Improved transdermal delivery system |
| 06/07/2011 | CA2473068C Starch derivatives, starch active-substance conjugates, method for their preparation and their use as drugs |
| 06/07/2011 | CA2471144C Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 06/07/2011 | CA2442971C Chemotherapeutic induction of egr-1 promoter activity |
| 06/07/2011 | CA2418422C Novel kallikrein gene |
| 06/07/2011 | CA2405705C The treatment of respiratory diseases |
| 06/07/2011 | CA2404431C Guanylyl cyclase c in the detection of stomach and esophageal cancers |
| 06/07/2011 | CA2377627C Cartilage enhancing food supplements and methods of preparing the same |
| 06/07/2011 | CA2322954C Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 06/07/2011 | CA2306216C The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting |
| 06/07/2011 | CA2213759C Method for treating amyloidosis |
| 06/03/2011 | WO2011065968A1 Use of monocyte chemoattractant compounds to treat ocular disorders |
| 06/03/2011 | WO2011065475A1 Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby |
| 06/03/2011 | WO2011065389A1 Method for screening of therapeutic agent for hyperlipemia |
| 06/03/2011 | WO2011064755A1 Compositions comprising amino acids for treating chronic obstructive pulmonary disease |
| 06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 06/03/2011 | WO2011064474A1 Pharmaceutical composition containing strontium salt, vitamin d, and cyclodextrin |
| 06/03/2011 | WO2011064352A1 Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin |
| 06/03/2011 | WO2011064297A1 Combination for the treatment of radiation - or chemotherapy - induced mucositis |
| 06/03/2011 | WO2011042565A3 Antiprotozoal activity of an efflux inhibitor with an anti-protozoal drug |
| 06/03/2011 | WO2010049078A8 Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension |
| 06/03/2011 | WO2008151415A8 Combination for treatment of diabetes mellitus |
| 06/03/2011 | WO2006119507A3 Non-nucleotide composition and method for inhibiting platelet aggregation |
| 06/03/2011 | CA2782179A1 Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin |
| 06/03/2011 | CA2781820A1 Combination for the treatment of radiation- or chemotherapy-induced mucositis |
| 06/03/2011 | CA2780650A1 Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method |
| 06/02/2011 | US20110130462 Aqueous Organic Acidic Solution for Sterilization and Microbial Growth Inhibition |
| 06/02/2011 | US20110129813 2'-branched nucleosides and flaviviridae mutation |
| 06/02/2011 | US20110129503 Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy |
| 06/02/2011 | US20110129448 Methods to mobilize progenitor/stem cells |
| 06/01/2011 | EP2327451A2 Method for detecting and inhibiting angiogenesis |
| 06/01/2011 | EP2327422A1 Activin antagonists for diagnosis and therapy of diseases associated with fibrosis |
| 06/01/2011 | EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy |
| 06/01/2011 | EP2327403A2 Pharmaceutical combinations of at least two bronchodilators |
| 06/01/2011 | EP2326329A1 Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
| 06/01/2011 | EP2326328A1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity |
| 06/01/2011 | EP2326325A1 Compounds for the treatment of peripheral neuropathies |
| 06/01/2011 | EP2326320A1 2, 4-disulfonyl pheny tert-butyl nitrone for the treatment of gliomas |
| 06/01/2011 | EP2326311A1 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
| 06/01/2011 | EP2326182A1 Composition and method to modify sperm fertility and female gender ratio in mammals |
| 06/01/2011 | EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers |
| 06/01/2011 | DE202010007433U1 Gel, insbesondere Gleitgel Gel, especially Lube |
| 06/01/2011 | CN1997370B Use of n-sulfamoyl-n'-arylpiperazines in preparing medicine for the prophylaxis or treatment of obesity and related conditions |
| 06/01/2011 | CN1934103B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/01/2011 | CN102083466A Niacin and NSAID combination therapy |
| 06/01/2011 | CN102083448A Immunotherapeutic agent and immunotherapy for pancreatic cancer |
| 06/01/2011 | CN102083437A Treatment of herpes virus related diseases |
| 06/01/2011 | CN102083430A Anti-tumoural effects of cannabinoid combinations |
| 06/01/2011 | CN102083426A Cannabinoids in combination with non -cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents) |
| 06/01/2011 | CN102083419A Pharmaceutical composition containing surface-coated microparticles |
| 06/01/2011 | CN102083417A Novel dosage and formulation |
| 06/01/2011 | CN102083416A Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| 06/01/2011 | CN102078621A Method and composition of regulating and controlling plasmacytoid dendritic cell I type interferon expression |
| 06/01/2011 | CN102078616A Esomeprazole sodium bicarbonate composition |
| 06/01/2011 | CN102078615A Composition of proton pump inhibitor and gastric mucosa protective agent |
| 06/01/2011 | CN102078614A Method for inhibiting shortsightedness and application of adenylate cyclase inhibitor as medicament for inhibiting shortsightedness |
| 06/01/2011 | CN102078613A Inhibitors of her3 activity |
| 06/01/2011 | CN102078612A Nasal in-situ gel containing mometasone furoate and H1 receptor antagonist |
| 06/01/2011 | CN102078611A Partial external use composition containing povidone Iodine and cyclodextrin inclusion glucocorticoid |
| 06/01/2011 | CN102078610A Application of combination of DCK (deoxycytidine kinase) analogue and CYP3A4 inhibitor |
| 06/01/2011 | CN102078597A Methods for treating muscle injuries |
| 06/01/2011 | CN102078309A Dispersible tablet containing antipsychotic medicines and application thereof |
| 06/01/2011 | CN102078297A Method for preparing osmotic diuretic injection containing high oxygen or electrolyte |
| 06/01/2011 | CN102078285A Nasal in-situ gel containing corticosteroids and H1 receptor antagonists |
| 06/01/2011 | CN101396370B Medicine composition for treating mouth, throat disease and preparation method thereof |
| 05/31/2011 | US7951931 Nucleic acid encoding sodium channel SCN3A alpha subunits |
| 05/31/2011 | US7951847 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951793 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/31/2011 | US7951786 Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides |
| 05/31/2011 | US7951772 Tumor-activated prodrug compounds and treatment |
| 05/31/2011 | US7951614 Methods and compositions for the production of monoclonal antibodies |
| 05/31/2011 | US7951398 Pharmaceutical preparation comprising an active dispersed on a matrix |
| 05/31/2011 | US7951397 Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 05/31/2011 | US7951394 Device and methods of sequential, regional delivery of multiple cyctotoxic agents and directed assembly of wound repair tissues |
| 05/31/2011 | US7951386 Recombinant cytochrome oxidase and/or morula membrane protein for use in developing therapeutics which prevent infection associated with mite parasitfes |
| 05/31/2011 | US7951364 CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis |
| 05/31/2011 | US7951356 Tissue factor compositions and kits for coagulation and tumor treatment |
| 05/31/2011 | CA2521182C Composition for improving cognition and memory |
| 05/31/2011 | CA2501365C Inhibitors of akt activity |
| 05/31/2011 | CA2483241C Novel diazabicyclononene derivatives |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2466135C Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease |
| 05/31/2011 | CA2438661C Yeast screens for agents affecting protein folding |
| 05/31/2011 | CA2416566C Depot formulation comprising ceftiofur and peroxidized natural oil |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2398929C Neuroprotective, antithrombotic and anti-flammatory uses of activated protein c (apc) |
| 05/26/2011 | WO2011062263A1 Pharmaceutical composition |
| 05/26/2011 | WO2011062147A1 Method for inducing differentiation of dental pulp cells into odontoblasts |